Feng Yan is an accomplished professional in the field of analytical and process development, currently serving as Associate Director at IMMORNA since March 2022, focusing on the development of mRNA vaccines and therapeutics. Previous experience includes roles at Istari Oncology overseeing analytical methods for oncolytic virus immunotherapy and at GSK Vaccines, where expertise was applied in analytical method development for protein and mRNA vaccines. Academic training includes a BS in Chemistry from Nankai University, an MS in Chemistry from Peking University, and a PhD in Biochemistry from Case Western Reserve University. Additional postdoctoral research was conducted at Duke University and the University of North Carolina at Chapel Hill, specializing in antibody validation and cancer cell studies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices